Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 15, 2010 - Issue 2
Submit an article Journal homepage
262
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for the treatment of benign prostatic obstruction

Hashim Hashim Bristol Urological Institute, Southmead Hospital, Bristol, BS10 5NB, UK+ 44 117 959 5690; + 44 117 950 2229; [email protected]
, MD FRCS FEBU &
Paul Abrams Bristol Urological Institute, Bristol, UK
, MD FRCS
Pages 159-174 | Published online: 06 May 2010

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stavros Gravas & Jean JMCH de la Rosette. (2013) Investigational therapies targeted to the treatment of benign prostatic hyperplasia. Expert Opinion on Investigational Drugs 22:3, pages 357-368.
Read now

Articles from other publishers (8)

Kyung Jin Chung & Benjamin I. Chung. (2017) Expected Next-Generation Drugs Under Development in Relation to Voiding Symptoms. International Neurourology Journal 21:2, pages 97-101.
Crossref
Xu-Guang Guo. (2016) Environmental estrogens have an impact on the ERs and their signaling in ER-responsive tissues and organs. International Urology and Nephrology 48:6, pages 1005-1006.
Crossref
Giacomo Novara, Vincenzo Ficarra & Filiberto Zattoni. 2014. Male LUTS/BPH Made Easy. Male LUTS/BPH Made Easy 67 87 .
Evan Goldfischer, John J. Kowalczyk, William R. Clark, Erin Brady, Michael Anne Shane, Nancy Dgetluck & Suzanne R. Klise. (2012) Hemodynamic Effects of Once-daily Tadalafil in Men With Signs and Symptoms of Benign Prostatic Hyperplasia on Concomitant α1-Adrenergic Antagonist Therapy: Results of a Multicenter Randomized, Double-Blind, Placebo-controlled Trial. Urology 79:4, pages 875-882.
Crossref
Yanqun Na, Zhangqun Ye & Shanzhong Zhang. (2012) Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia. Clinical Drug Investigation 32:1, pages 29-39.
Crossref
Hartmut Porst, Edward D. Kim, Adolfo R. Casabé, Vincenzo Mirone, Roberta J. Secrest, Lei Xu, David P. Sundin & Lars Viktrup. (2011) Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial. European Urology 60:5, pages 1105-1113.
Crossref
Brian A. Parsons & Hashim Hashim. (2011) Emerging Treatment Options for Benign Prostatic Obstruction. Current Urology Reports 12:4, pages 247-254.
Crossref
S Ventura, VL Oliver, CW White, JH Xie, JM Haynes & B Exintaris. (2011) Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH). British Journal of Pharmacology 163:5, pages 891-907.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.